0.5757
price down icon10.33%   -0.0663
after-market After Hours: .61 0.0343 +5.96%
loading

Ovid Therapeutics Inc Stock (OVID) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
4.55%
0.148
0.1416 0.109 0.075 0.0662
Operating Expenses
4.17%
17.57
18.33 12.14 14.25 14.96
Benefits Costs and Expenses
23.42%
11.84
15.46 11.36 12.48 13.42
Costs And Expenses
23.42%
11.84
15.46 11.36 12.48 13.42
Operating Income/Loss
4.24%
-17.42
-18.19 -12.03 -14.17 -14.89
Income/Loss From Continuing Operations Before Tax
-11.69
- -11.25 -12.41 -13.36
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
-11.69
- -11.25 -12.41 -13.36
Net Income/Loss
23.68%
-11.69
-15.32 -11.25 -12.41 -13.36
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
195.97K%
70.72
0.0361 70.62 70.53 70.49
Diluted Average Shares
195.97K%
70.72
0.0361 70.62 70.53 70.49
Basic Earnings Per Share
22.73%
-0.17
-0.22 -0.16 -0.18 -0.19
Diluted Earnings Per Share
22.73%
-0.17
-0.22 -0.16 -0.18 -0.19
Undistributed Earnings/Loss Allocated To Participating Securities, Basic
-
- - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$79.89
price up icon 2.27%
$32.25
price up icon 1.67%
$4.47
price down icon 5.10%
$353.31
price up icon 2.22%
biotechnology ONC
$221.22
price up icon 0.71%
$114.50
price down icon 0.67%
Cap:     |  Volume (24h):